SECT: Cognitive Remediation of Schizophrenia in a Community Mental Health Setting

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT01988714
Collaborator
(none)
112
1
2
84.8
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the usefulness of neuroscience-guided cognitive training combined with community-based supported employment for people with schizophrenia. The investigators will examine the effectiveness of moving our study of neuroplasticity-based restorative targeted cognitive training out of the laboratory and into the community setting; and the investigators will also investigate its utility in enhancing functional outcome in chronically mentally ill adults who are participating in supported employment.

Condition or Disease Intervention/Treatment Phase
  • Other: (TCT) plus evidence-based SE
  • Other: (CG) plus evidence-based SE
N/A

Detailed Description

Neurocognitive functioning will be assessed at baseline (study entry), after cognitive training (6 months), and at 12 month follow-up, using the MATRICS Consensus Cognitive Battery (MCCB). The investigators will assess the following six constructs identified by MATRICS as separable, fundamental dimensions of cognitive impairment in schizophrenia, with a likely sensitivity to intervention [26]: 1) Speed of Processing, 2) Attention/Vigilance, 3) Working Memory, 4) Verbal Learning and Memory, 5) Visual Learning and Memory, and 6) Reasoning and Problem Solving (executive functioning). The investigators will also administer the delayed memory trials of HVLT and BVMT, Trails B, and D-KEFS Color-Word Interference Test [27], and will make one modification to the MCCB in utilizing BACS Tower of London [28] in place of NAB Mazes.

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Sep 26, 2016
Actual Study Completion Date :
Sep 26, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: (TCT) plus evidence-based SE

(TCT) plus evidence-based SE

Other: (CG) plus evidence-based SE
(CG) plus evidence-based SE

Placebo Comparator: (CG) plus evidence-based SE

(CG) plus evidence-based SE

Other: (TCT) plus evidence-based SE
Targeted cognitive computer training (TCT) plus evidence-based SE in a community setting

Outcome Measures

Primary Outcome Measures

  1. Neurocognition improvement [24 months]

    Schizophrenia subjects who receive 80 hours of targeted cognitive training (TCT) plus evidence-based SE in a community setting will show, compared to baseline, greater improvements in neurocognition at 10 weeks, 20 weeks, 6 months, 12 months, 18 months, and 24 months than subjects who receive 80 hours of computer games (CG) plus SE.

Secondary Outcome Measures

  1. employment [24 months]

    Schizophrenia participants who receive 80 hours of TCT plus SE will have higher rates of employment 12, 18, and 24 months than those who receive 80 hours of CG plus SE.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosis of schizophrenia or schizoaffective disorder(DSM-IV criteria)

  • between the ages of 18-65

  • English as primary language (learned before age 12)

  • no major medical or neurological disorder that precludes participation in the study

Exclusion Criteria:
  • We will not exclude subjects with substance abuse or dependence as we wish to investigate the real-world effectiveness of this cognitive remediation approach when combined with SE. As per the clinical policy at Community Services, however, patients will not be permitted to attend the SE program or to participate in the study if they are acutely intoxicated. Subjects who miss 5 consecutive days of participation due to intoxication will be dropped and a replacement subject will be recruited.

Contacts and Locations

Locations

Site City State Country Postal Code
1 vinogradov research lab SFVAMC San Francisco California United States 94115

Sponsors and Collaborators

  • University of California, San Francisco

Investigators

  • Principal Investigator: Sophia Vinogradov, MD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01988714
Other Study ID Numbers:
  • R01MH068725
First Posted:
Nov 20, 2013
Last Update Posted:
Apr 5, 2019
Last Verified:
Apr 1, 2019
Keywords provided by University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2019